Famotidine
Potent H2 receptor antagonist in USP/EP/BP grade for oral tablet formulation manufacturing. Sourced for duodenal and gastric ulcer maintenance, and GERD treatment product lines.
← All CategoriesAPI Portfolio
Anti Ulcerants APIs
Proton pump inhibitors supplied as raw powder and enteric-coated pellet intermediates, plus H2 blockers, in USP/EP grade for capsule and tablet formulation manufacturing across global GI product lines.
Regulatory ReadyCOA, DMF & CEP supportUSP / EP / BPPharmacopoeial grade APIsFull TraceabilityBatch-to-batch documentation
Request Anti Ulcerants API Catalogue
All Anti Ulcerants APIs
Page 1 of 1
6 APIs available
Lafutidine
Dual-action H2 receptor antagonist and mucosal protective agent in pharmaceutical grade for oral tablet formulation manufacturing. Note: limited formal USP/EP monograph documentation — confirm grade specification with supplier.
Lansoprazole Powder / Pellets
Benzimidazole proton pump inhibitor supplied as raw crystalline powder and enteric-coated pellets — same active compound, USP/EP grade — for capsule and MUPS formulation manufacturing.
Omeprazole Powder / Pellets
First proton pump inhibitor supplied as raw crystalline powder and enteric-coated pellets — same active compound, USP/EP grade — for capsule and delayed-release tablet formulation manufacturing.
Pantoprazole Pellets
Proton pump inhibitor supplied as sodium sesquihydrate salt in enteric-coated pellet form — USP/EP grade — for delayed-release capsule formulation manufacturing. Sourced for erosive oesophagitis and Zollinger-Ellison syndrome protocols.
Rabeprazole Pellets
Proton pump inhibitor supplied as sodium salt in enteric-coated pellet form for delayed-release capsule formulation manufacturing. Sourced for GERD and duodenal ulcer treatment product lines.
WHO-GMP Certified Sources
Global Delivery
Regulatory Support
Consistent Quality
Secure Packaging / Custom Options